Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Recursion Pharmaceuticals, Inc. Banner

Recursion Pharmaceuticals, Inc.

RXRX Stock Analysis

Page title

Section title

About Recursion Pharmaceuticals, Inc.

Biotechnology
Healthcare

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis...

Recursion Pharmaceuticals, Inc. Key Metrics

Market Cap
$2B
52 Weeks Low
$5.62
52 Weeks High
$15.74
P/B
3.11x
P/E
-4.32x
P/S
24.75x

Upcoming Events

    RXRX Analyst Forecasts

    ‌
    ‌

    RXRX Financials

    RXRX Income Statement Key Metrics

    • Revenue(TTM)65.18 M
    • Gross Profit(TTM)1.96 M
    • EBITDA(TTM)-366.27 M
    • Net Income(TTM)-377.58 M
    • EPS Diluted(TTM)-1.5299999999999998

    Decode RXRX's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    RXRX earnings and revenue history

    Gross Profit Margin vs Peers

    Profit margin ratio of RXRX (-0.146) is lower than the average of its peers (0.038).

    Net Profit Margin vs Peers

    Net profit margin ratio of RXRX (-7.360) is lower than the average of its peers (-5.058).

    RXRX Return on Equity

    See how efficiently RXRX generates profit for it's shareholders.

    -70.79%

    10
    0
    100

    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of RXRX (-0.708) is higher than the average of its peers (-0.896).

    Return on Equity Growth

    RXRX's Return on Equity has shown poor growth over the past 10 years, increasing by only -7.07%.

    RXRX Revenue Growth

    See how RXRX has grown it's revenue over the past 10 years.

    ‌

    Revenue Growth

    RXRX's revenue has grown significantly over the past 10 years, increasing by over 91.94%.